Proceedings Of The 26Th Annual General Meeting Of Marksans Pharma Limited Held On Thursday, September 27, 2018.
Proceedings of the 26th Annual General Meeting of Marksans Pharma Limited held on Thursday, September 27, 2018. This is to inform you that the 26th Annual General Meeting ('AGM') of Marksans Pharma Limited ('the Company') was held on Thursday, September 27, 2018 and the business mentioned in the Notice dated August 25, 2018 was transacted. This Has Reference To The Exchange'S E-Mail Communication Dated 30Th August, 2018 For Clarification On The Board Meeting Held On 25Th August, 2018.
This has reference to the exchange's e-mail communication dated 30th August, 2018 for clarification on the board meeting held on 25th August, 2018. In this connection we state as under. 1. The Board of Directors of the Company at its meeting held on 25th August, 2018 recommended M/s Bhuta Shah & Co. LLP, Chartered Accountants to the shareholders for appointment as the Statutory Auditors in the casual vacancy caused by resignation of the... Book Closure Date Saturday, 22Nd September, 2018 To Thursday, 27Th September, 2018 (Both Days Inclusive).
Book Closure Date:- Saturday, 22nd September, 2018 to Thursday, 27th September, 2018 (Both Days inclusive). Purpose:- Annual General Meeting and payment of Dividend. The 26th Annual General Meeting of the Company will be held on Thursday, 27th September, 2018. Dividend, if declared at the Annual General Meeting, will be paid on or after 4th October, 2018. Notice For Convening 26Th Annual General Meeting On Thursday, 27Th September, 2018.
Dear Sir, Enclosed herewith the notice for convening 26 Annual General Meeting (AGM) of the Company scheduled to be held on Thursday, 27th September, 2018. The Company is providing e-voting facility to its shareholders, in respect of all shareholders resolutions, to be passed at the AGM. The e-voting period will start on 24th September, 2018 at 09:00 A.M. and will end on 26th September, 2018 at 05:00 P.M.... Announcement under Regulation 30 (LODR)-Appointment of Statutory Auditor/s
Dear Sir, This is to inform you that M/s. V. S. Lalpuria & Co., Statutory Auditor of the Company have resigned as Statutory Auditor with effect from the conclusion of the forthcoming Annual General Meeting of the Company. This is further to inform you that the Board of Directors of the Company at its meeting held today i.e. 25th August, 2018, has recommended M/s. Bhuta Shah & Co. LLP (FR No. W100100) to the shareholders for appointment... Announcement under Regulation 30 (LODR)-Press Release / Media Release
Enclosed herewith kindly find a News Release dated 6th August, 2018 of the Company. You are requested to note the above in your records. Result Financial Unaudited Result For The Quarter Ended 30.06.2018
Result Financial Unaudited result for the quarter ended 30.06.2018 Board Meeting Intimation for Meeting Of The Board Of Directors Of The Company Will Be Held On Monday, 6Th August, 2018 At Mumbai, To Consider And Approve The Unaudited Financial Results Of The Company (Both Standalone And Consolidated) For The Quarter Ended 30Th June, 2018.
MARKSANS PHARMA LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 06/08/2018 ,inter alias, to consider and approve This is to inform you that the Meeting of the Board of Directors of the Company will be held on Monday, 6th August, 2018 at Mumbai, to consider and approve the Unaudited Financial Results of the Company (both Standalone and Consolidated) for the quarter ended 30th June, 2018.... Shareholding for the Period Ended June 30, 2018
Marksans Pharma Ltd has submitted to BSE the Shareholding Pattern for the Period Ended June 30, 2018. For more details, kindly Click here Statement Of Investor Complaints For The Quarter Ended June 2018
No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0330 Name of the Signatory :- Harshavardhan PanigrahiDesignation :- Company Secretary and Compliance Officer